Premium
The basophil proteome in chronic spontaneous urticaria distinguishes responders to omalizumab from non‐responders
Author(s) -
Stitt J. M.,
Dzieciatkowska M.,
Edwards M. G.,
Hansen K.,
Hedlund G.,
Dreskin S. C.
Publication year - 2018
Publication title -
clinical and experimental allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/cea.13149
Subject(s) - omalizumab , basophil , medicine , immunology , proteome , intensive care medicine , immunoglobulin e , antibody , bioinformatics , biology